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Background: The correlation between primary tumor volume and nasopharyngeal carcinoma (NPC) UICC 2002 T
classification, N classification and distant metastasis after radiation therapy was discussed to provide further
evidence for the inclusion of tumor volume into the TNM classification staging system.
Methods: Between February 2001 and December 2008, 666 patients with NPC treated with intensity-modulated
radiation therapy (IMRT) were analyzed retrospectively. Primary gross tumor volume was calculated from treatment
planning computed tomography scans. The Kruskal-Wallis and Mann–Whitney tests were used for comparison of
continuous variables and the chi-square test was used for categorical variables. A logistic regression model was
used for multivariate analysis.
Results: Median primary tumor volume of the 666 patients was 20.35 ml (range, 0.44 − 192.63 ml), and it gradually
increased with T classification. Statistically significant differences in tumor volume were observed between patients
with different T classifications (p < 0.001). The cervical lymph node metastasis rate was 64.7% (430/666); the
differences in primary tumor volume between patients with or without lymph node metastasis were statistically
significant (p < 0.001). Posttreatment distant metastasis occurred in 100 NPC patients, and the five-year distant
metastasis-free survival was 84.2%. Univariate and multivariate analyses showed that N classification (p < 0.001) and
tumor volume (p = 0.007) were the main factors influencing distant metastasis.
Conclusion: Tumor volume was correlated with T classification, cervical lymph node mestastasis and distant
metastasis after radiation therapy in nasopharyngeal carcinoma, suggesting that tumor volume should be included
into the TNM staging system.
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The TNM classification of malignant tumors is based on
three components: the primary tumor, regional lymph
node metastasis and distant metastasis [1]. In an ideal
tumor staging system, the tumor (T) classification
should not only reflect the status of local invasion, but
also have close correlationships with regional lymph
node metastasis and distant metastasis. However, the* Correspondence: suyong@sysucc.org.cn
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reproduction in any medium, provided the orlimitations of the current T staging system of nasopha-
ryngeal carcinoma for determining tumor burden have
been described in several studies [2,3]. The T classifica-
tion system has also been shown to have a poor ability
to predict distant metastases and overall survival in pa-
tients treated with intensity-modulated radiation therapy
(IMRT) [4,5]. Therefore, it is important to establish new
prognostic and staging indicators to improve the existing
T classification system.
Tumor volume has a linear relationship with tumor
burden and is considered the most direct indicator of
tumor burden, which is significantly correlated with the
prognosis of most of malignant tumors [6-8]. In addition,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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dose is a fundamental principle of modem radiation biol-
ogy. The most direct explanation for these is that tumor
volume is correlated with the number of clonogenic tumor
cells to be eliminated. Moreover, the insufficient blood sup-
ply at the center of tumors with a large volume causes an
increase in the number of hypoxic and quiescent cells,
resulting in poor sensitivity of tumor cells to radiation and
the need for a higher radiotherapy dose to achieve curative
effects. Dubben et al. reviewed the effect of tumor volume
on the outcome of radiotherapy in several malignancies
and concluded that tumor volume is the most precise and
most relevant predictor of radiotherapy outcome. Individ-
ual tumor volumes should therefore be included in clinical
studies and considered in data analyses [8].
In nasopharyngeal carcinoma, tumor volume is not in-
cluded in the UICC TNM staging system, Ho’s staging
system or the Chinese 1992 staging system [1,9,10]. The
T stagings of these classification systems are mainly
based on local anatomic invasion, and the cranial nerve
involved, and lack indicators that can objectively and
quantitively reflect tumor burden. Several studies have
demonstrated that the prognosis prediction for patients
undergoing conventional radiotherapy or IMRT for
nasopharyngeal carcinoma using tumor volume is super-
ior than with the T staging system, and suggested that
tumor volume should be included in the TNM staging
of nasopharyngeal carcinoma [2,11,12]. However, the in-
clusion of tumor volume into the existing TNM staging
framework requires further study, and the correlation
between tumor volume and TNM staging also needs to
be clarified. Although the correlation between tumor
volume and the T classification has been investigated,
few studies have addressed the correlation between the
N classification and distant metastasis after radiotherapy.
Therefore, the aim of the present study was to explore
the correlation between tumor volume and the T and N
classifications and distant metastasis after radiotherapy,
and to provide further evidence for the inclusion of
tumor volume into the TNM staging system.
Methods
Patients
Between February 2001 and December 2008, 1070 stage
I-IVB NPC patients with definite histopathology diagno-
sis underwent IMRT at the Cancer Center of Sun Yat-
Sen University. Of these patients, 404 cases were excluded
from the study including 392 patients who received
neoadjuvant chemotherapy and 12 patients who under-
went neck mass resection biopsy before radiotherapy. A
total of 666 patients who underwent pure radiotherapy,
concurrent chemoradiotherapy, or concurrent chemo-
radiotherapy with adjuvant chemotherapy were included in
the retrospective analysis.The routine pretreatment evaluation included a complete
medical history, physical examination, nasopharyngoscopy,
chest radiography, abdominal region ultrasonography,
bone scintigraphy, hematologic and biochemical profile,
and magnetic resonance imaging (MRI) or computed tom-
ography (CT) of the head and neck. All patients underwent
disease staging using the UICC 2002 staging system [1].
Patient Immobilization and CT Simulation
Patients were immobilized in a supine position with a
head-neck-shoulder thermoplastic mask. CT simulation
(Plus 4, Siemens, Erlangen, Germany) was performed at
a slice thickness of 3 mm from the vertex of the head to
2 cm below the clavicle. Plain CT and contrast-enhanced
CT images were obtained and transferred to the inverse
IMRT workstation (CORVUS 3.0/3.2, Peacock plan) de-
veloped by the NOMOS Corporation.
Target delineation and primary tumor volume
measurement
The definition of target volumes and critical adjacent
organs, the prescribed doses and plan evaluation cri-
terion were described previously by Xiao et al. [13].
All target volumes (gross tumor volume and two clin-
ical target volumes) and critical adjacent organs were
outlined slice-by-slice on the axial fused images of
plain and contrast-enhanced CT images in the treat-
ment planning system in combination with MRI im-
ages. The treatment plans were evaluated and approved
by three to four radiation oncologists specializing in
NPC. The plan was approved upon meeting the evalu-
ation criteria of our institution.
The system can automatically reconstruct a 3D image
and calculate the volume of the tumor targets and crit-
ical organs. In this study, primary gross tumor volume
(GTVp) included the gross tumor volume of the primary
tumor and enlarged retropharyngeal lymph nodes.
Treatment
Radiation was delivered with a linear accelerator (Varian,
Palo Alto, CA) using 6 MV photons. IMRT was deliv-
ered with a dynamic multi-leaf intensity-modulating col-
limator (NOMOS Corporation, Sewickley, PA) using a
slice-by-slice arc rotation approach. In our protocol, pri-
mary tumors and the upper neck above the cricoid car-
tilage were treated with IMRT, whereas the lower neck
and the supraclavicular fossae were treated with a single
anterior split field by conventional RT. The details were
described previously by Xiao et al. [13].
Of all cases included, 373 patients with stage II–IV
disease received chemotherapy, 321 patients received
concurrent chemotherapy, and 52 patients received con-
current chemotherapy plus adjuvant chemotherapy. All
chemotherapy regimens were based on platinum drugs.
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Events were measured from the beginning of IMRT.
After radiotherapy completion, the patients were sub-
sequently followed-up monthly for the first 3 months.
Then, patients were followed-up every 3 months from
3 months through 3 years, and every 1 year thereafter.
Complete physical and fiberoptic nasopharyngoscopy
or indirect nasopharyngeal speculum examinations
were performed. Biochemistry profiles, chest radiog-
raphy, abdominal ultrasonography, and MRI of the
nasopharynx and cervical region were routine ele-
ments of the assessment. Further investigations were
arranged as indicated.
Statistical methods
The different groups were compared with respect to
baseline characteristics, using the Kruskal-Wallis and
Mann–Whitney tests for comparison of continuous vari-
ables and the chi-square test for categorical variables. A
logistics regression model was used for multivatiate ana-
lysis. The Kaplan-Meier method was used for survival
analysis. SPSS 13.0 software (SPSS Inc, Chicago, IL,
USA) was used for all data analyses. Statistical signifi-
cance was set at p ≤ 0.05.
Results
Patient characteristics
Patient characteristics are listed in Table 1. The median
follow-up time was 51 months (range, 3–130 months)
by December 31, 2011.
During follow-up, thirty-three cases of local failure
were found, distant metastasis occurred in 100 cases,
and 101 patients died. The five-year local failure-free
survival, distant metastasis-free survival, and overall sur-














Abbreviations: WHO indicates World Health Organization.Relationship between tumor volume and T classification
The median primary tumor volume of the 666 patients
was 20.35 ml (range, 0.44 − 192.63 ml), and it gradually
increased in correlation with T classification. The me-
dian primary tumor volume for the T1 classification was
5.56 ml (range, 0.44 − 40.89 ml); for the T2 classification,
15.06 ml (range, 1.42 − 93.20 ml); for the T3 classifica-
tion, 26.37 ml (range, 3.27 − 127.44 ml); and for the T4
classification, 65.9 ml (range, 9.52 − 192.63 ml). The dif-
ferences in tumor volume among the different T stages
were statistically significant by the Kruskal-Wallis test
(p < 0.001). The differences in primary tumor volume be-
tween the T2 and T1, T3 and T2, and T4 and T3 classi-
fications were statistically significant (p < 0.001, all)
according to the Wilcoxon test. The distribution of pri-
mary tumor volumes among different T stages is illus-
trated in Figure 1. A wide variation in tumor volumes
was observed within the same T classification, in particu-
lar in advanced tumors. However, there was also overlap
between the volumes in the different T classifications.
Relationship between tumor volume and N classification
The cervical lymph node metastasis rate for nasopharyn-
geal carcinoma in the present study was 64.7% (430/666).
The median nasopharyngeal tumor volume of N0 classi-
fication patients was 14.6 ml (range, 0.44 − 106.74 ml); in
N + patients, the median tumor volume was 24.59 ml
(range, 1.11 − 192.63 ml). The differences in primary tumor
volume between patients with or without lymph node me-
tastasis were statistically significant, as determined by the
Mann–Whitney test (p < 0.001). In N + patients, the me-
dian nasopharyngeal tumor volume of N1-stage patients
was 23.09 ml (range, 1.44 − 188.02 ml), that of N2 patients
was 27.21 ml (range, 1.11 − 192.63 ml), and that of N3-Figure 1 Correlation between T classification and primary gross
tumor volume.
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Statistical analysis showed that the differences in tumor
volume among N1, N2 and N3 stages were not signifi-
cant (p = 0.097).
Relationship between tumor volume and distant metastasis
The median tumor volume in patients with distant me-
tastasis was 35.75 ml (range, 5.22 − 192.63 ml), and that
in distant metastasis-free cases was 18.25 ml (range,
0.44 − 188.02 ml). The differences in primary tumor vol-
ume between patients with or without distant metastasis
were statistically significant by the Mann–Whitney test
(p < 0.001). The chi-square test showed that T classifica-
tion (p < 0.001) and N classification (p < 0.001) were sig-
nificantly associated with distant metastasis. Further
multivariate logistic analysis showed that N classification
(p < 0.001) and tumor volume (p = 0.007) were the two
main factors influencing distant metastasis after treat-
ment, whereas T classification did not significantly cor-
relate with distant metastasis (Table 2).
Discussion
vThe results of the present study indicated that there is
a close relationship between tumor volume and T classi-
fication. The Kruskal–Wallis test showed that tumor
volume increased significantly with advancing T classifi-
cation. Similarly, the Wilcoxon rank-sum test indicated
that tumor volume was significantly greater in patients
with more advanced T classifications than in those with
adjacent early T classifications. However, there was sig-
nificant variation within the same T classification, in par-
ticular in advanced tumors. At the same time, obvious
overlaps were observed in the different T classifications
(Figure 1). These results were consistent with those of
Chua et al. [2] and Chong et al. [3], and provided fur-
ther evidence that the existing T staging system is lim-
ited with respect to the assessment of tumor burden.Table 2 Results of multivariate analysis: risk factors for






Primary tumor volume 1.012 1.003-1.022 0.007








Abbreviations: ref indicates reference.Similar cases could be observed in clinical practice. For
example, the invasion of the skull base in nasopharyn-
geal carcinoma is considered as a T3 classification, des-
pite significant differences in the degree of invasion;
single or multiple skull bases may be invaded, and even
when the same skull base is invaded, the severity of the
invasion can also differ. A study has confirmed that dif-
ferences in the severity of skull base invasion are asso-
ciated with different prognoses [14]. Therefore, the
deficiency of the T staging in this respect may affect the
formulation of a treatment strategy. This may cause de-
viations in the judgement of disease severity and the
prognosis of patients. In addition, conservative treat-
ment strategies adopted for large-volume tumors of an
early stage may also result in ineffective therapy, even
treatment failure. Therefore, tumor volume should be
included in the T staging system to improve the deter-
mination of tumor burden, accurately identify the con-
dition of the patient, and assist in the selection of a
suitable treatment strategy.
Although the patterns of lymph node metastasis of
nasopharyngeal carcinoma have been investigated
[15,16], few studies have examined the relationship be-
tween nasopharyngeal tumor volume and cervical
lymph node metastasis. In the present study, the lymph
node metastasis rate was 65.4%. Statistical analyses
showed that there were significant differences in naso-
pharyngeal tumor volume between patients with or
without lymph node metastasis. The increase of pri-
mary tumor volume could have resulted in the infiltra-
tion of the parapharyngeal space and invasion of
surrounding structures, which have been shown to have
a close relationship with cervical lymph node metasta-
sis [17,18]. However, in the present cases, the minimum
tumor volume in patients with lymph node metastasis
was only 1.11 ml. In the patients with lymph node me-
tastasis, there were no significant differences in tumor
volume in the different N classifications, which could
be attributed to the high lymph node metastasis rate of
nasopharyngeal carcinoma and metastasis occurrence
in early-stage patients.
The majority of nasopharyngeal carcinoma cases are
characterized by the presence of poorly differentiated or
undifferentiated tumors, with high probability of distant
metastasis. In patients undergoing IMRT, distant metas-
tasis is also the most important reason for treatment
failure and high mortality rates [4,19]. Therefore, the
analysis of the risk factors for distant metastasis in naso-
pharyngeal carcinoma patients is important. Studies have
shown a close relationship between N classification sta-
tus and distant metastasis [4,5]. However, deficiencies in
the detection of distant metastasis on the basis of the T
classification system have been reported [4,5], suggesting
that the modification of the existing T staging system is
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sis. Tumor volume could serve as a potential independ-
ent factor. Large tumor volumes are indicative of the
proliferation of tumor cells over a relatively long period
of time or a high proliferation rate and malignancy of
tumor cells, which are associated with distant metastasis.
However, previous studies have mainly focused on the
influence of tumor volume on local control and overall
survival, with little investigation into the relationship be-
tween tumor volume and distant metastasis [11,12]. In
our study, univariate and multivariate analyses showed
that N classification and tumor volume were the main
factors influencing distant metastasis of NPC, suggesting
that tumor volume may be useful for predicting distant
metastasis. The possible incorporation of tumor volume
into the T staging system may result in a modified TNM
staging system with an improved capacity to predict the
occurrence of distant metastasis.
However, in NPCs treated by conventional radiother-
apies, tumor volume has not been considered as an im-
portant clinical prognostic factor. This could be due to
the common occurrence of infiltration in nasopharyn-
geal carcinoma, as well as the irregular shape of tumors
and the difficulties in assessing tumor volume. To over-
come this problem, several authors have developed
semiautomated or automated systems to measure tumor
volume [20]. With the advent of three-dimensional con-
formal radiotherapy technology, it is already possible to
precisely measure the primary tumor volume. The three-
dimensional volume of tumors and the corresponding
exposure dose and coverage also become crucial factors
in the formulation, optimization and assessment of clin-
ical radiotherapy schemes. These factors provide strong
support for the inclusion of tumor volume as an import-
ant prognostic factor in clinical staging.
The present retrospective study had certain limita-
tions. A total of 392 patients receiving neoadjuvant
chemotherapy were excluded, as the delineation of the
GTV target was influenced by chemotherapy in some
cases. Notably, the exclusion of patients receiving
neoadjuvant chemotherapy would also affect an inves-
tigation into the effect of chemotherapy in advanced
stage patients. At the same time, the patients who re-
ceived induction chemotherapy were mainly III-IV
stage patients. The exclusion of these patients from
our study also affected the distribution of patients.
Conclusions
The present study demonstrated that tumor volume was
closely related with nasopharyngeal carcinoma T classifi-
cation, cervical lymph node metastasis and distant me-
tastasis after radiotherapy. The current T staging system
has certain limitations in accurately reflecting tumor
burden; variation within the same T classification waswide, especially for advanced tumors. Meanwhile, obvi-
ous overlaps were observed in the different T classifica-
tions. Tumor volume may be a potential indicator for
predicting distant metastasis in nasopharyngeal carcin-
oma. Therefore, the inclusion of tumor volume into the
UICC staging system is reasonable and feasible for naso-
pharyngeal carcinoma.
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